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The histone chaperone FACT plays an important role in facilitating nucleosome
assembly and disassembly during transcription. FACT is a heterodimeric
complex consisting of Spt16 and SSRP1. The N-terminal domain of Spt16
resembles an inactive aminopeptidase. How this domain contributes to the
histone chaperone activity of FACT remains elusive. Here, the crystal structure
of the N-terminal domain (NTD) of human Spt16 is reported at a resolution
of 1.84 A˚. The structure adopts an aminopeptidase-like fold similar to those
of the Saccharomyces cerevisiae and Schizosaccharomyces pombe Spt16 NTDs.
Isothermal titration calorimetry analyses show that human Spt16 NTD binds
histones H3/H4 with low-micromolar affinity, suggesting that Spt16 NTD may
contribute to histone binding in the FACT complex. Surface-residue conserva-
tion and electrostatic analysis reveal a conserved acidic patch that may be
involved in histone binding.
1. Introduction
Eukaryotes package their DNA into nucleosomes, which
consist of four histone proteins, H2A, H2B, H3 and H4, that
associate to form two H2A/H2B heterodimers and one H3/H4
heterotetramer. Two H2A/H2B heterodimers and one H3/H4
heterotetramer associate to form an octamer around which
147 bp of DNA are wrapped (Luger et al., 1997). Histone
chaperones play important roles in directing histone deposi-
tion into DNA and histone disassembly from the nucleosome
to facilitate DNA replication, transcription and DNA-damage
response (Gurard-Levin et al., 2014).
Facilitating chromatin transcription (FACT) is a histone
chaperone consisting of a heterocomplex of suppressor of
Ty 16 (Spt16) and structure-specific recognition protein 1
(SSRP1). Early in vitro studies showed that FACT displaces
the H2A/H2B dimer from the nucleosome template to facil-
itate RNA polymerase II-driven transcription and has the
ability to deposit histones onto DNA (Orphanides et al., 1998,
1999). Subsequent studies showed that when FACT is incu-
bated with H2AX and the nucleosome, it can catalyse the
exchange of H2AX with H2A within the nucleosome (Heo et
al., 2008) and compete against DNA for H2A/H2B binding but
not the H3/H4 tetramer (Winkler et al., 2011). These studies
support a model in which FACT functions as an H2A/H2B
exchanger. A recent study has shown that yeast FACT can
relax DNA–histone interactions without removing H2A/H2B
and the loss of dimer is likely to be owing to reorganization of
the destabilized nucleosome (Xin et al., 2009). Nonetheless, to
destabilize the nucleosome, FACT is likely to disrupt DNA–
histone interactions by binding directly to the histones.
Indeed, early studies showed that FACT and both subunits
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of FACT can bind histones (Belotserkovskaya et al., 2003;
Formosa et al., 2001). Moreover, affinity analyses showed that
FACT interacts with the core domains and N-terminal tails
of both histones H2A/H2B and H3/H4 through several
synergistic binding events involving both Spt16 and SSRP1
(Winkler et al., 2011). How Spt16 and SSRP1 interact with
histones remains elusive.
SSRP1 contains an N-terminal Spt16-binding domain
followed by a middle domain (MD) and a C-terminal HMG
domain. SSRP1 MD adopts two pleckstrin-homology (PH)
folds and has been shown to bind histone H3/H4 (VanDemark
et al., 2006; Zunder et al., 2012). Genetic analysis of yeast
SSRP1 MD revealed that some mutations, including Q308K,
can induce temperature sensitivity, hydroxyurea sensitivity
and an Spt phenotype, suggesting the importance of this
domain in transcription and DNA replication, possibly
through interactions with histones (VanDemark et al., 2006).
The HMG domain has been shown to bind nucleosomal DNA
and this interaction causes DNA bending, leading to minor-
groove widening that may disrupt DNA–histone interactions
(Masse et al., 2002; Kasai et al., 2005).
Spt16 consists of an NTD followed by an SSRP1 dimer-
ization domain, MD and C-terminal domain. Spt16 MDs from
Chaetomium thermophilum and Saccharomyces cerevisiae
have been shown to interact with histone H3/H4, and
C. thermophilum Spt16 MD also binds H2/H2B (Kemble et al.,
2013; Hondele et al., 2013). The structure of Spt16 MD reveals
two PH domains in tandem and it shares structural similarity
with SSRP1 MD and RTT106; however, it has three additional
-helices located at the C-terminus that form a U-turn motif.
This motif interacts with the H2A/H2B dimer via hydrophobic
interactions with residues on the H2B 1 helix (Hondele et al.,
2013). Interestingly, most of the Spt16 mutations that affect
FACTactivity are in Spt16 MD (Myers et al., 2011; Formosa et
al., 2001). These mutations can be suppressed by destabilizing
H2A/H2B dimer and H3/H4 tetramer interactions (Myers
et al., 2011; McCullough et al., 2011; Hainer et al., 2012),
suggesting that Spt16 MD is responsible for establishing
important interactions with the nucleosome. The Spt16
C-terminal domain consists of highly intrinsically disordered
acidic residues. Removal of these regions hampers the ability
of FACT to bind nucleosomes and histones and to promote
transcription (Belotserkovskaya et al., 2003; Myers et al.,
2011). A recent structural study showed that the Spt16 and
SSRP1 C-terminal flexible acidic residues contain a tyrosine or
phenylalanine residue, respectively, that binds to a hydro-
phobic pocket in H2B (Kemble et al., 2015). This interaction
overlaps with nucleosomal DNA–H2A/H2B interactions,
suggesting that FACT might promote reorganization of the
nucleosomes by competing with DNA for histone binding.
The function of Spt16 NTD remains unclear. Studies in
yeast showed that deletion of this domain or mutations in
specific conserved residues do not disrupt essential functions
of yeast FACT. However, when combined with the yeast
SSRP1 MD Q308K mutation that causes defects in DNA
replication and transcription, the effect is lethal, suggesting
that Spt16 NTD functionally overlaps with SSRP1 MD
(O’Donnell et al., 2004; VanDemark et al., 2008). Furthermore,
genetic analyses showed that Spt16 NTD might interact with
the C-terminal extension of H2A (VanDemark et al., 2008).
The structures of Spt16 NTD from S. cerevisiae and Schizo-
saccharomyces pombe (PDB entries 3bip and 3cb5, respec-
tively) reveal an aminopeptidase-like domain that resembles a
‘pita-bread’ fold and which has lost its aminopeptidase activity
(Stuwe et al., 2008; VanDemark et al., 2008). Studies on
S. pombe Spt16 NTD showed that it forms a tight complex
with histone H3/H4. Moreover, it binds H3 and H4 N-terminal
tails with low-micromolar affinity (Stuwe et al., 2008). In
contrast, no binding of histone N-terminal tails could be
observed with S. cerevisiae Spt16 NTD (VanDemark et al.,
2008). To further elucidate the role of Spt16 NTD in histone
interactions, we determined the crystal structure of human
Spt16 NTD and examined its histone-binding ability.
2. Materials and methods
2.1. Macromolecule production
The gene for human Spt16 NTD (residues 1–510) was
cloned into pGEX-4T-1 vector (Novagen) using standard PCR
ligation techniques such that the protein is expressed with an
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Table 1
Crystallization.
Method Hanging-drop vapour diffusion
Plate type 24-well hanging-drop plate
Temperature (K) 292
Protein concentration (mg ml1) 13.3
Buffer composition of protein
solution
25 mM Tris–HCl pH 7.6, 150 mM NaCl,
1 mM DTT
Composition of reservoir solution 0.1M sodium acetate pH 5.0, 17%(w/v)
PEG 3350, 0.1M ammonium iodide
Volume and ratio of drop 2 ml, 1:1 ratio
Volume of reservoir (ml) 0.5
Table 2
Data collection and processing.
Values in parentheses are for the outer shell.
Diffraction source DLS beamline I02
Wavelength (A˚) 0.979493
Temperature (K) 100
Detector Pilatus 6M
Crystal-to-detector distance (mm) 264.6
Rotation range per image () 0.85
Total rotation range () 90
Exposure time per image (s) 0.5
Space group F432
a, b, c (A˚) 246.57, 246.57, 246.57
, ,  () 90, 90, 90
Mosaicity () 0.13
Resolution range (A˚) 87.18–1.84 (1.88–1.84)
Total No. of reflections 1124024 (72859)
No. of unique reflections 56315 (4094)
Completeness (%) 100.0 (100.0)
Multiplicity 20.0 (17.8)
hI/(I)i 28.1 (4.2)
Rr.i.m.† 0.084 (0.822)
Rp.i.m. 0.019 (0.193)
Overall B factor from Wilson plot (A˚2) 22.67
† Estimated Rr.i.m. = Rmerge[N/(N  1)]1/2, where N is the data multiplicity.
N-terminal glutathione S-transferase (GST) tag followed by a
TEV protease cleavage site. The resulting vector was trans-
formed into Escherichia coli BL21 (DE3) Gold competent
cells. The cells were grown at 310 K in LB to an OD600 of
0.7–0.8 and then induced with 0.2 mM isopropyl -d-1-
thiogalactopyranoside overnight at 293 K. The following day,
the cells were harvested and resuspended in 50 mM Tris–HCl
pH 7.6, 0.2MNaCl, 1 mMDTT, 2.5 mM phenylmethylsulfonyl
fluoride, 1 mg ml1 lysozyme and then subjected to a freeze–
thaw cycle. The cells were lysed by sonication and then
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Figure 2
Crystal structure of human Spt16 NTD. (a, b) Structure of human Spt16 NTD in two orientations. The domain consists of an N-terminal lobe (residues 1–
175, blue) and a C-terminal lobe (residues 176–432, light blue). (c, d) Superimposition of human (blue), S. cerevisiae (green; PDB entry 3bip) and
S. pombe (orange; PDB entry 3cb5) Spt16 NTD structures. (c) and (d) are displayed in the same orientations as (a) and (b), respectively. Arrows indicate
variations in the loops owing to differences in protein sequence and length.
Figure 1
Purity and crystals of human Spt16 NTD. (a) SDS–PAGE showing fractions of human Spt16 NTD after Superdex 75 gel-filtration chromatography. (b)
Crystals of human Spt16 NTD.
centrifuged at 48 000g for 25 min at 277 K using a JA-25.50
rotor (Beckman Coulter) to remove cell debris. GST-Spt16
NTD was purified from the lysate by glutathione Sepharose
affinity chromatography. The GST tag was released by incu-
bation with TEV protease and subsequently removed with a
glutathione Sepharose column. Cleaved Spt16 NTD was then
purified by anion-exchange chromatography (Source Q, GE
Life Sciences) in buffer consisting of 50 mM Tris–HCl pH 7.6,
1 mM DTT, 0–1M NaCl and by size-exclusion chromato-
graphy (Superdex 75, GE Life Sciences) in buffer consisting of
25 mM Tris–HCl pH 7.6, 150 mM NaCl, 1 mM DTT. Fractions
containing Spt16 NTD were pooled together and concentrated
to about 13.3 mg ml1. The protein was then cooled in liquid
nitrogen and stored at 193 K. Gallus gallus histone octamer
proteins (H2A, H2B, H3 and H4) were purified from chicken
blood (Lambert et al., 1999) and separated into histones H2A/
H2B and H3/H4 by cation-exchange chromatography (Source
S, GE Life Sciences) using a 0–2M KCl gradient in buffer
consisting of 50 mM KH2PO4, 50 mM K2HPO4 pH 6.5, 1 mM
DTT. Proteins were then frozen in liquid nitrogen and stored
at 193 K.
2.2. Crystallization
Spt16 NTD (13.3 mg ml1) was mixed with an equal volume
of reservoir solution consisting of 0.1M sodium acetate
pH 5.0, 17%(w/v) PEG 3350, 0.1M ammonium iodide using
the hanging-drop vapour-diffusion method at 292 K. Crystals
appeared after 1 d and were flash-cooled in 0.1M sodium
acetate pH 5.0, 17%(w/v) PEG 3350, 0.1M ammonium iodide,
20%(w/v) glycerol (Table 1).
2.3. Data collection and processing
Diffraction data from human Spt16 NTD crystals were
collected on beamline I02 at Diamond Light Source (DLS).
Data obtained at 100 K were integrated, merged and scaled
using the automated XDS (Kabsch, 2010; Winter, 2010)
method applied at the beamline. Data-collection and proces-
sing statistics are shown in Table 2.
2.4. Structure-solution and refinement statistics
Human Spt16 NTD crystals belonged to space group F432
with one molecule in the asymmetric unit. Initial phases were
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Table 3
Structure-solution and refinement statistics.
Values in parentheses are for the outer shell.
Resolution range (A˚) 61.64–1.84 (1.88–1.84)
Completeness (%) 100.0
No. of reflections, working set 53453 (2634)
No. of reflections, test set 2857 (130)
Final Rcryst 0.156 (0.203)
Final Rfree 0.176 (0.215)
No. of non-H atoms
Protein 3420
Solvent 458
Total 3878
R.m.s. deviations
Bonds (A˚) 0.008
Angles () 1.216
Average B factors (A˚2)
Protein 28.4
Ramachandran plot
Most favoured (%) 98.9
Allowed (%) 100
Figure 3
Putative binding site of Spt16 NTD for the H4 N-terminal tail. (a) Superimposition of Spt16 NTD structures from human (blue), S. cerevisiae (green;
PDB entry 3bip) and S. pombe (orange; PDB entry 3cb5) showing a close-up view of the H4 N-terminal tail-binding site on the N-lobe. The Ser83 and
Lys86 side chains located on the 3 helix on the S. pombe Spt16 NTD structure and the corresponding Ser and Lys in human and S. cerevisiae Spt16 NTD
are indicated. (b) Overall structure of human Spt16 NTD showing the location of the 3 helix.
obtained by molecular replacement with Phaser (Storoni et al.,
2004) using S. cerevisiae Spt16 NTD (PDB entry 3biq; 32%
sequence identity to human Spt16 NTD; VanDemark et al.,
2008) as the initial search model. The model was built in Coot
(Emsley & Cowtan, 2004) and refined using PHENIX (Adams
et al., 2010). The structure of human Spt16 NTD was refined to
1.84 A˚ resolution. The model contains only chain A (residues
2–432). Residues 433–510 were absent from the electron
density. Side chains with poor electron density were built as
stubbed residues. Details of the refinement statistics are shown
in Table 3.
2.5. Isothermal titration calorimetry
Binding interactions between human Spt16 NTD and
histones H2A/H2B, H3/H4 or the N-terminal tails of H3 or H4
were analysed by ITC using an iTC200 (MicroCal, GE Life
Sciences). Experiments were conducted at 298 K with buffer
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Figure 4
ITC profiles of human Spt16 NTD against (a) histone H4 N-terminal tail, (b) histone H3 N-terminal tail, (c) H2A/H2B and (d) H3/H4. (a, b) Raw data
for the N-terminal peptide from H4 (blue) and H3 (green), respectively, titrated into human Spt16 NTD. (c) ITC profile showing raw data (upper panel)
and integrated raw data (lower panel) for the titration of human Spt16 NTD against H2A/H2B. (d) ITC profile showing raw data (upper panel) and
integrated data (lower panel) for the titration of human Spt16 NTD against H3/H4.
consisting of 20 mM HEPES–NaOH pH 7.5, 150 mM NaCl,
1 mM TCEP. Histone H2A/H2B or H3/H4 was loaded into the
cell at a concentration of 30–40 mM. Human Spt16 NTD was
loaded into the injection syringe at a concentration ten times
higher than that of the histones in the cell. For interactions of
Spt16 NTD with H3 or H4 N-terminal peptides, human Spt16
NTD was loaded into the cell at a concentration of 50 mM
while histone H3 or H4 peptides were loaded into the syringe
at a concentration 10–20 times higher than that of Spt16 NTD
in the cell. 20 injections (2 ml each) were added every 180 s to
the cell. For control experiments, buffer was injected into the
cell containing the protein. ITC data were generated by
subtracting the raw data from the control experiment and
were then analyzed using the Origin software (v.7). The
histone N-terminal peptides sequences are MARTKQTA-
RKSTGGKAPRKQLATKAARKSAPSTGGVKK for H3
(Abgent) and MSGRGKGGKGLGKGGAKRHRKVLRDN
for H4 (Abgent). Peptides were weighed and dissolved in
Milli-Q water at 50 mM and then diluted into the appropriate
buffer.
3. Results and discussion
3.1. Crystal structure of human Spt16 NTD
Our human Spt16 NTD construct consists of residues 1–510.
The purified protein gave a band at between 49 and 62 kDa
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Figure 5
Electrostatic surface potential (3 to 3kT) comparison of human, S. pombe and S. cerevisiae Spt16 NTD. Electrostatic surface representations of (a)
human, (b) S. pombe and (c) S. cerevisiae Spt16 NTD in different views generated using APBS (Baker et al., 2001) in PyMOL (Schro¨dinger). S. pombe
Spt16 NTD reveals a larger acidic surface at the conserved pocket than that observed in S. cerevisiae and human Spt16 NTD. The left panel is in the same
orientation as in Fig. 2(a); the middle and right panels are rotated 90 and 180 about the horizontal axis, respectively. (d, e) Top and bottom view,
respectively, of human Spt16 NTD as shown in the left panel in (a). The arrow indicates the location of the conserved pocket.
(Fig. 1a), which agrees with the calculated molecular weight of
57.9 kDa. The protein crystallized at 292 K after 1 d (Fig. 1b)
and these crystals diffracted to a resolution of 1.84 A˚ with
space group F432 and one molecule of Spt16 NTD per
asymmetric unit. While the construct contains residues 1–510,
electron density for residues 433–510 was not visible. The
structure of human Spt16 NTD reveals two lobes: an N-lobe
comprising residues 1–175 and a C-lobe comprising residues
176–432. Although human Spt16 NTD shares only 32 and 35%
sequence identity with the structurally characterized S. cere-
visiae and S. pombe Spt16 NTDs, respectively, it adopts a
similar aminopeptidase-like fold in which the C-lobe resem-
bles a pita-bread fold (Figs. 2a and 2b; Stuwe et al., 2008;
VanDemark et al., 2008). Superimposition of the human Spt16
NTD structure onto the structures of Spt16 NTD from
S. cerevisiae (r.m.s.d. of 1.22 A˚ for all C atoms) and S. pombe
(r.m.s.d. of 0.86 A˚ for all C atoms) shows slight differences in
the loop regions in the N- and C-lobes owing to variations
in the amino-acid sequences and lengths (Figs. 2c and 2d).
Despite the presence of a linker between the two lobes, the
orientation of the two lobes appears to be rigid across the
three Spt16 NTD structures.
3.2. Human Spt16 NTD binds histone H3/H4 with
micromolar affinity
Earlier studies on S. pombe Spt16 NTD show that it forms a
1:1 complex with the H3/H4 dimer but that it does not bind the
H2A/H2B dimer in pull-down experiments. Moreover, it binds
histone H3 and H4 N-terminal tails with low-micromolar
affinity (Stuwe et al., 2008). A pocket harbouring Ser83 and
Lys86 in S. pombe Spt16 NTD was shown to be involved in
binding the H4 N-terminal tail. These residues are conserved
in both human and S. cerevisiae Spt16 NTD and they adopt
a similar configuration in all three structures (Fig. 3). This
prompted us to investigate whether human Spt16 NTD has a
role in binding histones and histone N-terminal tails.
To assess whether human Spt16 NTD binds the histone H3
and H4 N-terminal tails, we performed ITC experiments to
measure the binding affinity between human Spt16 NTD and
the H3 or H4 N-terminal peptides. ITC experiments showed
that there was no enthalpy change when H3 or H4 peptide was
added to human Spt16 NTD (Figs. 4a and 4b), suggesting that
human Spt16 NTD does not bind histone H3 or H4 N-terminal
tails or that the interaction is too weak to be detected at the
concentrations used in our assays. It is noteworthy that our
assay was performed at 150 mM NaCl concentration, while in
the studies of S. pombe Spt16 NTD 25 mM NaCl was used.
Stuwe and coworkers have shown that the salt concentration
influences the interaction of Spt16 NTD with histone tails in
vitro (Stuwe et al., 2008). Unfortunately, human Spt16 NTD
precipitated heavily and rapidly at 25 mM NaCl, thus
preventing further analysis. It is likely that these interactions
depend on the ionic strength used in the in vitro binding assays
and this may differ between species. Another possible expla-
nation that may account for the differences in histone-tail
binding abilities across different species is that the human and
S. pombe Spt16 NTD structures have different electrostatic
surface potentials (Fig. 5). Consistent with this suggestion, no
binding of histone N-terminal tails is observed with S. cere-
visiae Spt16 NTD (VanDemark et al., 2008).
To examine whether human Spt16 NTD binds histones, we
performed ITC analyses of human Spt16 NTD against H2A/
H2B or H3/H4. An ITC experiment with human Spt16 NTD
against H2A/H2B showed very little change in enthalpy when
Spt16 NTD was added to H2A/H2B, suggesting that Spt16
NTD does not bind H2A/H2B or binds with a very weak
affinity. On the other hand, human Spt16 NTD binds histones
H3/H4 with low-micromolar affinity (Kd of 2.84  0.61 mM;
N = 0.88  0.03; Figs. 4c and 4d). Together, these data show
that human Spt16 NTD is likely to bind H3/H4 via the core
histone.
3.3. A conserved pocket on Spt16 NTD might contribute to
histone binding
To explore how human Spt16 NTD may interact with
histones, we analysed the surface-residue conservation of
Spt16 NTD to identify hypothetical patches that may be
involved in histone binding. Sequence alignment of Spt16
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Figure 6
Sequence conservation of Spt16 NTD. Sequence alignment of Spt16 NTD from human, Danio rerio, S. cerevisiae, S. pombe, Drosophila melanogaster,
Xenopus laevis,Dictyostelium discoideum and Chaetomium thermophilum was performed and the sequence conservation was mapped onto the structure
of human Spt16 NTD. (a), (b) and (c) are in the same orientation as in the left, middle and right panels of Fig. 5(a), respectively. The conserved pocket is
indicated by an arrow. Residues that are more than 80% conserved are highlighted in red and the rest are coloured grey.
NTD from various species was performed and the sequence
conservation was mapped onto the structure of human Spt16
NTD (Fig. 6). The analysis revealed clusters of conserved
residues on the C-lobe and in a pocket between the N-lobe
and the C-lobe. Furthermore, electrostatic surface analysis of
human Spt16 NTD showed an acidic patch that co-localizes
within this conserved pocket (Fig. 5a, middle panel),
suggesting a possible role of this region in histone interaction.
The electrostatic maps also show acidic patches at the bottom
of the C-lobe and at the top of the N-lobe that may be
potential histone-binding sites (Figs. 5d and 5e). Further
studies are required to elucidate how Spt16 NTD interacts
with histones. Our data are consistent with previous studies
suggesting that Spt16 NTD is likely to play a supportive role
with other FACT domains in modulating nucleosome
assembly.
4. Conclusion
Little is known about Spt16 NTD and its functions. Here, we
have reported the crystal structure of human Spt16 NTD and
shown that it adopts a structure similar to those of S. cerevisiae
and S. pombe Spt16 NTDs. Our ITC analyses showed that
human Spt16 NTD is likely to bind histones H3/H4 through
the histone core. Analysis of Spt16 NTD sequences from
various species and the electrostatic surface of this domain
reveal the presence of a conserved acidic pocket that may be
involved in histone binding (Fig. 5a, middle panel, and
Fig. 6b). Interestingly, some Spt16 NTD mutations that are
lethal in conjunction with SSRP1 mutations cluster in a region
near this conserved pocket (VanDemark et al., 2008). Further
studies will be required in order to elucidate how FACT
domains cooperate to bind histones.
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